Jelmyto fda approval date?

When did Jelmyto (mitomycin) get FDA approval?

Jelmyto (mitomycin) received FDA approval on October 12, 2020. [1]

What indication was Jelmyto approved for on that date?

On its approval date, Jelmyto was approved for adult patients with low-grade upper tract urothelial cancer (UTUC) that is not eligible for or refuses surgery. [1]

Where can I verify the approval details and related patent/exclusivity info?

For a cross-check of approval timing and to explore related patent or exclusivity context, you can also look at DrugPatentWatch: [2]

Sources

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213316s000lbl.pdf
[2] https://www.drugpatentwatch.com/